| SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients D Geers, MC Shamier, S Bogers, G den Hartog, L Gommers, ... Science immunology 6 (59), eabj1750, 2021 | 567 | 2021 |
| Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals LM Zaeck, MM Lamers, BE Verstrepen, TM Bestebroer, ME Van Royen, ... Nature medicine 29 (1), 270-278, 2023 | 184 | 2023 |
| Persistent health problems beyond pulmonary recovery up to 6 months after hospitalization for COVID-19: a longitudinal study of respiratory, physical, and psychological outcomes ME Hellemons, S Huijts, LM Bek, JC Berentschot, G Nakshbandi, ... Annals of the American Thoracic Society 19 (4), 551-561, 2022 | 57 | 2022 |
| Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers MC Shamier, A Tostmann, S Bogers, J de Wilde, J IJpelaar, ... MedRxiv, 2021.08. 20.21262158, 2021 | 55 | 2021 |
| Extent and location of tumor-infiltrating lymphocytes in microsatellite-stable colon cancer predict outcome to adjuvant active specific immunotherapy AW Turksma, VMH Coupé, MC Shamier, KLH Lam, VA de Weger, ... Clinical cancer research 22 (2), 346-356, 2016 | 53 | 2016 |
| The role of antibody indexes in clinical virology MC Shamier, S Bogers, E Yusuf, M van Splunter, JCEM Ten Berge, ... Clinical Microbiology and Infection 27 (9), 1207-1211, 2021 | 20 | 2021 |
| SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci Immunol. 2021; 6: eabj1750 D Geers, MC Shamier, S Bogers, G den Hartog, L Gommers, ... Epub 2021/05/27. doi: 10.1126/sciimmunol. abj1750. PubMed PMID: 34035118, 0 | 18 | |
| Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay S Popping, R Molenkamp, JD Weigel, PGNJ Mutsaers, JC Voermans, ... Journal of Virological Methods 300, 114397, 2022 | 12 | 2022 |
| Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022 MC Shamier, LM Zaeck, HM Götz, B Vieyra, BE Verstrepen, K Wijnans, ... Eurosurveillance 29 (17), 2300532, 2024 | 10 | 2024 |
| Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers. medRxiv. 2021 Aug 21 MC Shamier, A Tostmann, S Bogers, J de Wilde, J IJpelaar, ... | 8 | |
| Brain stem encephalitis is a rare complication of COVID-19 MC Shamier, YS Crijnen, S Bogers, JW IJpelaar, JM de Vries, ... Journal of Neuroimmunology 374, 578007, 2023 | 5 | 2023 |
| Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023 LPM van Leeuwen, MC Shamier, BE Verstrepen, HM Götz, KS Schmitz, ... Eurosurveillance 29 (38), 2400575, 2024 | 4 | 2024 |
| The implications of mpox breakthrough infections on future vaccination strategies MC Shamier, LM Zaeck, RD de Vries, CH GeurtsvanKessel The Lancet Infectious Diseases 24 (1), 6-8, 2024 | 2 | 2024 |
| Looking back on the COVID-19 pandemic in an elite sports team using whole genome sequencing MC Shamier, LV Wismans, S van Boheemen, BBO Munnink, ... Journal of Science and Medicine in Sport 26 (4-5), 218-221, 2023 | 2 | 2023 |
| Mpox control strategies: using behaviour change to complement, not replace, vaccination MC Shamier, KJ Jonas The Lancet Infectious Diseases 24 (12), 1288-1289, 2024 | 1 | 2024 |
| Orthopoxvirus-specific antibodies wane to undetectable levels one year after MVA-BN vaccination of at-risk individuals LPM van Leeuwen, MC Shamier, BE Verstrepen, HM Götz, KS Schmitz, ... medRxiv, 2024.08. 13.24311601, 2024 | | 2024 |
| Humorale en cellulaire afweer tegen SARS-CoV-2 MC Shamier, D Geers, M Koopmans, R de Vries, CG van Kessel Ned Tijdschr Med Microbiol 31 (1), 5, 2023 | | 2023 |
| Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy A Turksma, V Coupe, M Shamier, K Lam, V de Weger, J Belien, ... Journal for ImmunoTherapy of Cancer 3, 1-2, 2015 | | 2015 |
| Extent and location of tumor infiltrating lymphocytes in colon cancer predicts outcome to adjuvant active specific immunotherapy E Hooijberg, AW Turksma, M Shamier, K Lam, VMH Coupe, VA Weger, ... Cancer Research 74 (19_Supplement), 1649-1649, 2014 | | 2014 |
| Extent and location of tumor infiltrating lymphocytes in micro-satellite stable colorectal cancer predicts outcome to adjuvant Active Specific Immunotherapy AW Turksma, MC Shamier, KLH Lam, VMH Coupé, VA de Weger, ... | | |
